Literature DB >> 7397667

Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol no. 4). VI. Discriminants for five-year treatment failure.

E R Fisher, C Redmond, B Fisher.   

Abstract

Thirty-six pathologic and six clinical characteristics observed in 581 patients enrolled in protocol no. 4 of the National Surgical Adjuvant Breast Project were treated by radical mastectomy and were correlated with five-year treatment failure. The cases were initially stratified according to pathologic nodal status, the most important discriminant in breast cancer. The presence of tumor necrosis, poor tumor differentiation (histologic grade 3) and a tumor size > 4 cm were found by multivariate analyses to influence treatment failure in patients without nodal metastases. Prognosis was usually worse in individuals whose tumors exhibited all of these features than in those in whom only one or two could be detected. Although the sample size was small, life-table analysis also disclosed a highly significant relationship between treatment failure and a germinal center predominance pattern in regional nodes in this subset of patients. Except for this latter, these same discriminants were similarly noted to affect treatment failure in those patients with four or more nodal metastases but not those with only 1--3 positive nodes. A possible explanation for this inconsistency among nodal categories is discussed. Nevertheless, it is concluded that these rather easily measured pathologic parameters represent important discriminants for the prognosis and the design of treatment schemes and subsequent protocols for patients with breast cancer, particularly those without regional nodal metastasis. The findings amplify the importance of intrinsic tumor characteristics as well as possibly host factors in accounting for the clinical behavior of patients with breast cancer.

Entities:  

Mesh:

Year:  1980        PMID: 7397667     DOI: 10.1002/1097-0142(19800815)46:4+<908::aid-cncr2820461310>3.0.co;2-5

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

Review 1.  Breast cancer in the elderly.

Authors:  M M Kemeny
Journal:  Bull N Y Acad Med       Date:  1992-11

2.  Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy.

Authors:  U Veronesi; B Salvadori; A Luini; A Banfi; R Zucali; M Del Vecchio; R Saccozzi; E Beretta; P Boracchi; G Farante
Journal:  Ann Surg       Date:  1990-03       Impact factor: 12.969

Review 3.  Breast cancer. Advances in management.

Authors:  G N Brodie; A Elefanty
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

4.  Prognosis in node-negative breast cancer.

Authors:  C J van de Velde; H S Gallager; G G Giacco
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 5.  Medullary cancer of the breast revisited.

Authors:  E R Fisher; J P Kenny; R Sass; N V Dimitrov; R H Siderits; B Fisher
Journal:  Breast Cancer Res Treat       Date:  1990-10       Impact factor: 4.872

6.  Portal lymphadenopathy associated with lipofuscin in chronic cholestatic liver disease.

Authors:  S G Hübscher; R F Harrison
Journal:  J Clin Pathol       Date:  1989-11       Impact factor: 3.411

Review 7.  Patterns of metastasis and natural courses of breast carcinoma.

Authors:  Y T Lee
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

8.  Breast cancer in women under 30 years of age.

Authors:  F Tabbane; A el May; M Hachiche; J Bahi; M Jaziri; M Cammoun; N Mourali
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

9.  Scar cancers: pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4) - IX.

Authors:  E R Fisher; A S Palekar; R Sass; B Fisher
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

Review 10.  The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer.

Authors:  T H Stewart; S C Tsai
Journal:  Clin Exp Metastasis       Date:  1993-07       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.